• Home
  • Grass Allergy
  • About GRADUATE
  • Study Location
  • COVID-19 Statement
  • About ITN
  • About RBH Allergy Dept
  • Privacy Policy
  • Policies, Standards & Legislation
  • Understanding Clinical Trials
Skip to main content
Immune Tolerance Network

Developing, funding and conducting clinical trials in immune tolerance

Share This
Home

A clinical trial exploring long-term protection from seasonal hay fever.

 

GRADUATE is no longer recruiting participants.

 

COVID-19 Statement

  • Home
  • Grass Allergy
  • About GRADUATE
  • Study Location

Grass Allergy

Allergies happen when your immune system overreacts to a substance (an allergen such as grass pollen) that would otherwise be harmless. Hay fever, also called allergic rhinitis, affects 23% of the UK and European population. Its symptoms generally include itchy, runny or stuffy nose and sneezing, and it can have a major impact on quality of life. 

Current treatment for seasonal grass allergy includes taking over the counter or prescription medications to help reduce the symptoms, although they do not eliminate the allergy.

Learn more about the GRADUATE study.

Thank you for your interest in our research. The study is no longer recruiting new participants.

  • About ITN
  • About the Team
  • Privacy Policy
  • Policies, Standards & Legislation
  • Understanding Clinical Trials

GRADUATE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded) | V1.3 | 2021-03-25 | REC Ref # 20/NW/0089
 

           

NIH National Institute of Allergy and Infectious Diseases